Last Updated : October 25, 2011
Details
FilesGeneric Name:
Oxybutynin Chloride Gel
Project Status:
Complete
Therapeutic Area:
Overactive bladder
Manufacturer:
Watson Pharma Company
Call for patient/clinician input open:
Brand Name:
Gelnique
Project Line:
Reimbursement Review
Project Number:
SR0260-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Bladder, overactive
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : October 25, 2011